|
Release date: Oct. 14, 2003 Emory Continues Rapid Growth in Research Funding in 2003
Contact: Emory University continued its rapid trajectory of research growth in FY03, receiving a total of $319.1 million in sponsored research funding. This represents an increase of $38 million, or 14 percent, over research funding in FY02. Over the past five years sponsored research funding at Emory has grown by more than 93 percent, making it one of the fastest growing research universities in the nation. Federal funding was responsible for more than 75 percent of the FY03 total, with funding from the National Institutes of Health (NIH) making up 61 percent of the total. The Woodruff Health Sciences Center received $295.5 million, more than 92 percent of the University total and a greater than 16 percent increase over FY02 funding. According to the Office of Sponsored Programs, research funding in the Rollins School of Public Health ($45.1 million) grew by 24 percent in FY03, funding in the School of Medicine ($204 million) grew by 17 percent, and funding in the Nell Hodgson Woodruff School of Nursing ($3.3 million) grew by 26 percent. Research funding for Yerkes National Primate Research Center was $43 million, an increase of 5 percent. Federal funding was responsible for 76 percent of Health Sciences Center funding, with funding from the NIH making up 65 percent of the total. “It is a significant and notable fact that Emory University scientists have won these research funds competitively, on a national basis, even within these difficult fiscal times,” said Emory University Vice President for Research Frank Stout. “These are dollars that have been brought into Georgia through the intellectual capability of our faculty, and these funds will provide additional support for the state’s economy.” The top ten departments within the University for funded research in FY03 were Department of Medicine (SOM), Department of Neurology (SOM), Department of Psychiatry (SOM), Department of Behavioral Sciences and Health Education (RSPH), Department of Pathology and Laboratory Medicine (SOM), Department of Surgery (SOM), Department of Pediatrics (SOM), Department of Epidemiology (RSPH), Yerkes National Primate Research Center Division of Administration, and Yerkes Department of Microbiology and Immunology. Collaborative research with other universities and interdisciplinary research within the University were hallmarks of the year’s funding. Research in vaccines, immunology, emerging infections and biodefense garnered substantial research dollars, including continuing development of HIV/AIDS vaccines within Yerkes National Primate Research Center, the Emory Vaccine Center, and the Department of Microbiology and Immunology in Emory University School of Medicine. Following years of federally funded research, an HIV vaccine developed at Emory and the NIH entered human clinical trials early in 2003. Emory received funding this year from the National Institute of Allergy and Infectious Diseases (NIAID) as a member of four new research consortia: (1) a Regional Center of Excellence for Emerging Infections and Biodefense led by Duke University, (2) an Emory-led Cooperative Center for Translational Research on Human Immunology and Biodefense; (3) a UAB-led consortium developing a new class of HIV vaccines; and (4) a collaborative project led by Novavax, Inc., to develop HIV vaccines. Emory’s Winship Cancer Institute (WCI) was award nearly $2 million through a National Cancer Institute Planning Grant – a critical first step in attaining designation as an NCI Compehensive Cancer Center. The WCI also received a $10 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop a consortium of 13 universities working to identify entirely new therapeutic targets and concepts for effective treatment of advanced prostate cancer. The NIH awarded the Emory Center for AIDS Research (CFAR) more than $7.3 million in a renewal of its CFAR status. Lung disease research received substantial funding in FY03, with $10 million from the NIH for two separate projects, one studying the effects of alcohol abuse on lung disease, and a multi-institutional investigation aimed at improving lung cancer detection in smokers. Researchers at the School of Public Health received $3 million from the Robert Wood Johnson Foundation as part of funding for the Tobacco Technical Assistance Consortium (TTAC) to assist states and communities in reducing tobacco use. Research funding in Emory College was $16.8 million in FY03. The Center for Fundamental and Applied Molecular Evolution (FAME), a jointly sponsored initiative between Emory College and Georgia Institute of Technology, received $600,000 in funding, partly from the National Science Foundation. FAME scientists study evolutionary principles and their application to the synthesis of novel molecules and materials. The interdisciplinary center focuses on fundamental questions at the interface between chemistry, biology, and physics. A sampling of the numerous other funded projects includes $2.2 million to the Candler School of Theology for its Youth Theological Initiative, $5 million for a School of Medicine collaboration with the Medical University of South Carolina and community clinicians for a Specialized Center of Research on Sex and Gender Factors Affecting Women’s Health (SCOR), $1.5 million to the School of Public Health for an Interfaith Health Program designed to promote community health in seven states, $5 million from the Helene Fuld Health Trust to the Nursing School for endowment support of an innovative program to increase the nation’s supply of university-trained nurse leaders, and $2.6 million for an interdisciplinary Digestive Diseases Research Center in the School of Medicine. ###
|
|
||||||||||||
 |
 |
 |
copyright 2001
For more information contact: